Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes.

Bishop FK, Wadwa RP, Ellis S, Rewers M, Maahs DM.

Int J Pediatr Endocrinol. 2012 Jul 30;2012(1):24. doi: 10.1186/1687-9856-2012-24.

PMID:
22846167
[PubMed]
Free PMC Article
2.

Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients.

Pratipanawatr T, Rawdaree P, Chetthakul T, Bunnag P, Ngarmukos C, Benjasuratwong Y, Leelawatana R, Kosachunhanun N, Plengvidhya N, Deerochanawong C, Suwanwalaikorn S, Krittiyawong S, Mongkolsomlit S, Komoltri C.

J Med Assoc Thai. 2006 Aug;89 Suppl 1:S60-5.

PMID:
17715835
[PubMed - indexed for MEDLINE]
3.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

Wright JT Jr, Cushman WC, Davis BR, Barzilay J, Colon P, Egan D, Lucente T, Nwachuku C, Pressel S, Leenen FH, Frolkis J, Letterer R, Walsh S, Tobin JN, Deger GE; ALLHAT Research Group.

Control Clin Trials. 2001 Dec;22(6):659-73.

PMID:
11738122
[PubMed - indexed for MEDLINE]
4.

Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators.

Wanner C, Krane V, Ruf G, März W, Ritz E.

Kidney Int Suppl. 1999 Jul;71:S222-6.

PMID:
10412782
[PubMed - indexed for MEDLINE]
5.

Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns.

Ruof J, Klein G, März W, Wollschläger H, Neiss A, Wehling M.

Prev Med. 2002 Jul;35(1):48-53.

PMID:
12079440
[PubMed - indexed for MEDLINE]
6.

Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Kingry C, Bastien A, Booth G, Geraci TS, Kirpach BR, Lovato LC, Margolis KL, Rosenberg Y, Sperl-Hillen JM, Vargo L, Williamson JD, Probstfield JL; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):68i-79i. Epub 2007 Apr 12.

PMID:
17599427
[PubMed - indexed for MEDLINE]
7.

Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.

Udawat H, Goyal RK.

Indian Heart J. 2001 Mar-Apr;53(2):172-6.

PMID:
11428472
[PubMed - indexed for MEDLINE]
8.

Screening for Lipid Disorders in Children and Adolescents [Internet].

Haney EM, Huffman LH, Bougatsos C, Freeman M, Fu R, Steiner RD, Helfand M, Nelson HD.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jul.

PMID:
20722144
[PubMed]
Books & Documents
9.

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

Vijan S, Hayward RA; American College of Physicians.

Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.

PMID:
15096337
[PubMed - indexed for MEDLINE]
10.

Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes.

Maahs DM, Wadwa RP, McFann K, Nadeau K, Williams MR, Eckel RH, Klingensmith GJ.

J Pediatr. 2007 Feb;150(2):146-50, 150.e1-2.

PMID:
17236891
[PubMed - indexed for MEDLINE]
11.

Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Pressel S, Davis BR, Louis GT, Whelton P, Adrogue H, Egan D, Farber M, Payne G, Probstfield J, Ward H; ALLHAT Research Group.

Control Clin Trials. 2001 Dec;22(6):674-86.

PMID:
11738123
[PubMed - indexed for MEDLINE]
12.

For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.

Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D.

Pharmacoepidemiol Drug Saf. 2008 May;17(5):485-94. doi: 10.1002/pds.1589.

PMID:
18383562
[PubMed - indexed for MEDLINE]
13.

Lipid-lowering therapy in diabetes mellitus.

Niemeijer-Kanters SD, Banga JD, Erkelens DW.

Neth J Med. 2001 May;58(5):214-22. Review.

PMID:
11414234
[PubMed - indexed for MEDLINE]
14.

LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.

Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.

J Manag Care Pharm. 2007 Oct;13(8):652-63.

PMID:
17970603
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006.

Fonarow GC, French WJ, Frederick PD.

Am Heart J. 2009 Jan;157(1):185-194.e2. doi: 10.1016/j.ahj.2008.09.001. Epub 2008 Oct 29.

PMID:
19081417
[PubMed - indexed for MEDLINE]
17.

Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data.

Lewis GF.

Can J Cardiol. 1995 May;11 Suppl C:24C-28C. Review.

PMID:
7750045
[PubMed - indexed for MEDLINE]
18.

Inadequate treatment of dyslipidemia in people with type 2 diabetes: quality assessment of diabetes care in a Danish County.

Kolding Kristensen J, Lauritzen T.

Scand J Prim Health Care. 2006 Sep;24(3):181-5.

PMID:
16923628
[PubMed - indexed for MEDLINE]
19.

Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.

Sanders BH, Lubsch LM, West DS.

Ann Pharmacother. 2006 Sep;40(9):1517-21. Epub 2006 Aug 8.

PMID:
16896016
[PubMed - indexed for MEDLINE]
20.

Lipid-lowering therapy in people with type 2 diabetes.

Colagiuri S, Best J.

Curr Opin Lipidol. 2002 Dec;13(6):617-23. Review.

PMID:
12441885
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk